ID Analysts

Our seasoned team of analysts continually monitors investment opportunities around the world, to provide investors with the widest possible array of money-making ideas.

Analyst Articles

Image via Wikipedia Volume 3, Number 52  December 27, 2006  It should be another relatively quiet week for trading this week. Much of both Wall Street and Main Street are on holiday as the year comes to an end and those that aren’t on vacation… Read More

Among our open positions, the Thai selloff and the inflation data has put pressure on small cap stocks, including our February 80 iShares Russell 2000 Index (IWM) call option (IOW + BB). Our short-term timing model for small caps is still bullish though and we’ve entered a period of seasonal… Read More

Image via Wikipedia Volume 3, Number 51  December 20, 2006  Like the wrapped presents sitting under department store Christmas trees these days, there’s less than meets the eye in the news reports that are hitting the airwaves lately. As with the empty store packages, the… Read More

One position we are willing to take on right now is the February 80 iShares Russell 2000 Index call option (IOW + BB). Our short-term timing models are telling us that small cap shares are offering the potential for a modest short-term gain with limited downside risk. Set a limit… Read More

Image via Wikipedia Volume 3, Number 50  December 13, 2006  The Federal Reserve’s policy setting body left short-term interest rates unchanged yesterday to no one’s surprise. The verbiage that came along with the inaction indicates that the central bank expects economic growth to pick up… Read More

Expectations for above-average temperatures in much of the country sent natural gas traders to the exits early in the week. Related stocks, including contract driller Nabors Industries (NBR) also came under pressure. Instead of risking the remaining gains on our Nabors March 35 call option (NBR + CG) we headed… Read More

Image by squareintheteeth via Flickr Volume 3, Number 49  December 6, 2006  We’re in the holiday spirit these days, but we see growing uncertainties in this market. With momentum players largely in control and season trends in their favor, we look for stocks to continue… Read More

Our only action in the past week was the sale of the Novartis January 60 call option on Monday for a nice 26 percent profit in less than two weeks. We were prompted by a sense that a modest pullback in share prices was in the works and as you… Read More

Image via Wikipedia Volume 3, Number 48  November 29, 2006  Gesundheit. Stocks showed the first sign of catching a cold Monday, suffering their worst one-day loss in five months. There was plenty of finger-pointing as to the cause, including the weak U.S. greenback, expectations for… Read More

Yesterday we doubled our exposure to Amylin Pharmaceuticals (AMLN), this time buying the Amylin March 40 call option (AMQ + DH). The stock has come under renewed pressure with slightly worse than expected script numbers in the latest week. Traders were so concerned with scripts they chose to ignore the… Read More